Ramy Riad: Advancing Plasma-Derived Therapies Through Partnership
Ramy Riad, President of Plasma-Derived Therapies Business Unit at Takeda, shared a post on LinkedIn:
“Wrapping up a productive first day at IPPC 2026, hosted by Plasma Protein Therapeutics Association (PPTA), with a real sense of momentum.
This year’s theme — ‘Resilience, Reach and Responsibility’ — perfectly captures the leadership imperative facing our industry.
No single organization can sustain the plasma ecosystem alone.
It requires long‑term partnerships and shared responsibility across the value chain.
Today’s conversations reinforced how essential collaboration is to protect access for the patients who depend on plasma-derived therapies.
Looking forward to the sessions ahead and to connecting with fellow leaders shaping the future of plasma.”
Stay updated with Hemostasis Today.
-
May 2, 2026, 15:16William Aird: When Platelets Rise in Infection
-
May 2, 2026, 15:16Emmanuel J. Favaloro: Clinical Challenges in Hemostasis Assessment for Suspected VTE and PE in Emergency Care
-
May 2, 2026, 15:15Chokri Ben Lamine: High-Yield Pearls from a Heme Perspective on Uremic Coagulopathy
-
May 2, 2026, 15:13Apply to Lead a Scientific Workshop at ASH26 – ASH
-
May 2, 2026, 15:11Vitamin C Testing May Be Worth Considering In BDUC- RPTH Journal
-
May 2, 2026, 15:08Ethology and Treatment of Iron Deficiency – Sociedad Iberoamericana de Patient Blood Management
-
May 2, 2026, 14:56Navigating Surgical Bleed Risk in Anticoagulation Management – Thrombosis Canada
-
May 2, 2026, 14:42Gareth Owens: EACTS Aortic Webinar on Heritable Thoracic Aortic Disease and Marfan Syndrome
-
May 2, 2026, 14:39William Wallace: Your Nerves Can Be Damaged Before Your Blood Shows It